S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
137 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Nea Medical Center - Stadium Boulevard
Jonesboro, Arkansas, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Burbank, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Tibotec Therapeutics - Division of Ortho Biotech Products, Lp
Marysville, California, United States
- El Camino Hospital Cancer Center
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
Orange, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
- Sutter Health - Western Division Cancer Research Group
San Rafael, California, United States
- Tahoe Forest Cancer Center
Truckee, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
- San Luis Valley Regional Medical Center
Alamosa, Colorado, United States
- University of Colorado Cancer Center at Uc Health Sciences Center
Aurora, Colorado, United States
- Shaw Regional Cancer Center
Edwards, Colorado, United States
- Valley View Hospital Cancer Center
Glenwood Springs, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Hawaii Medical Center - East
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Castle Medical Center
Kailua, Hawaii, United States
- Kauai Medical Clinic
Lihue, Hawaii, United States
- Maui Memorial Medical Center
Wailuku, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2010
- Primary completion
- 31 Oct 2013
- Completion
- 31 May 2014
- Last update posted
- 19 Dec 2016
- Registered enrollment
- 129
- Registry id
- NCT00872989
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.